The 20 Best RASopathies Doctors Near Me in District of Columbia, US

Patroula Smpokou is a Medical Genetics provider practicing medicine in Washington, Washington, D.c.. Dr. Smpokou is rated as a Distinguished provider by MediFind in the treatment of RASopathies. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses RASopathies, Noonan Syndrome, Lhermitte-Duclos Disease, and Bannayan-Riley-Ruvalcaba Syndrome.

Ramon Sanchez is a Pediatric Radiologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 33 years. Dr. Sanchez is rated as an Experienced provider by MediFind in the treatment of RASopathies. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hirschsprung Disease, Scoliosis, Caudal Regression Syndrome, and Spondylocarpotarsal Synostosis Syndrome. Dr. Sanchez is board certified in Pediatric Radiology: American Board Of Radiology, 2014 and Diagnostic Radiology: American Board Of Radiology, 2012.

Eglal Shalaby-Rana, MD, is a radiologist in the Division of Diagnostic Imaging and Radiology at Children's National Hospital. She is the director of performance improvement. Dr. Rana is rated as an Experienced provider by MediFind in the treatment of RASopathies. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Hirschsprung Disease, Scoliosis, Knock Knees, and Biliary Atresia. Dr. Rana is board certified in Pediatric Radiology: American Board Of Radiology, 1995 and Diagnostic Radiology: American Board Of Radiology, 1987.

Ravi Vegulla is a Pediatric Cardiologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 17 years. Dr. Vegulla is rated as an Experienced provider by MediFind in the treatment of RASopathies. His clinical expertise encompasses Ventricular Septal Defects, Kawasaki Disease, Patent Ductus Arteriosus, and Myocarditis. Dr. Vegulla is board certified in Pediatric Cardiology: American Board Of Pediatrics, 2022 and Pediatrics: American Board Of Pediatrics, 2018.

Andrew Dauber, MD, MMSc, is the chief of endocrinology at Children’s National Hospital. As a pediatric endocrinologist, Dr. Dauber works in all areas of pediatric endocrinology, but specializes in studying and treating growth disorders. Dr. Dauber has published more than 65 studies and regularly speaks at international pediatric endocrinology conferences, discussing a variety of topics, including clinical clues to identify rare genetic growth conditions, genetic factors that influence height and the timing of puberty, as well as novel genetic disorders that he has helped identify. He is the recipient of the 2020 Richard E. Weitzman Outstanding Early Career Investigator Award from the Endocrine Society for successfully applying innovative genetic technologies to pediatric endocrinology. With a medical degree and a Master’s of Medical Sciences in Clinical Investigation from Harvard Medical School, Dr. Dauber finds it natural to merge academic research with its clinical counterparts to accelerate cutting-edge treatment and multidisciplinary care. He is currently working with pediatric health centers to integrate genomics into patient registries and electronic health records, harnessing large data sets, including whole-exome sequences, to help clinicians identify and treat high-risk patients. Over the next few years, Dr. Dauber will create an endocrinology research program at Children’s National, transforming the type of care that children with endocrine disorders receive. This will make it easier for parents to find comprehensive resources for rare conditions, thyroid problems, growth disorders, early or delayed puberty, as well as type 1 and type 2 diabetes. Dr. Dauber also has experience with guiding joint infrastructures and engines of innovation. Previously, he served as the program director and director of translational research at the interdisciplinary Cincinnati Center for Growth Disorders at Cincinnati Children’s Hospital Medical Center. Additionally, he was the director of their Genomics First for Undiagnosed Diseases Program and guided medical residents and fellows as an associate professor of pediatrics at the University of Cincinnati. He held similar roles as the assistant medical director for the clinical research unit at Boston Children’s Hospital and as an assistant professor in pediatrics at Harvard Medical School. Dr. Dauber holds board certifications in pediatrics and pediatric endocrinology from the American Board of Pediatrics. He is an active member of and has received several awards and honors from the Endocrine Society, Pediatric Endocrine Society, European Society of Pediatric Endocrinology and the Society for Pediatric Research. Dr. Dauber is rated as an Advanced provider by MediFind in the treatment of RASopathies. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Short Stature (Growth Disorders), Hypochondroplasia, Precocious Puberty, and Growth Hormone Deficiency (GHD). Dr. Dauber is board certified in Endocrinology Diabetes And Metabolism: American Board Of Pediatrics, 2011 and Pediatrics: American Board Of Pediatrics, 2007.

Ellen Pritchett is a Dermatologist practicing medicine in Washington, Washington, D.c.. Dr. Pritchett is rated as an Experienced provider by MediFind in the treatment of RASopathies. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Hidradenitis Suppurativa, Vitiligo, GAPO Syndrome, and Keloids.

Jason Mitchell is a Pediatric Cardiologist practicing medicine in Washington, Washington, D.c.. Dr. Mitchell is rated as an Experienced provider by MediFind in the treatment of RASopathies. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Heart Murmurs, Patent Ductus Arteriosus, Ventricular Septal Defects, and Dextrocardia with Situs Inversus.

Sarika Snell is a Dermatologist practicing medicine in Washington, Washington, D.c.. Dr. Snell is rated as an Experienced provider by MediFind in the treatment of RASopathies. She is also highly rated in 68 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Comedones, Liver Spots, and Universal Acquired Melanosis.

Rohit Jain is an Endocrinologist practicing medicine in Washington, Washington, D.c.. Dr. Jain is rated as an Experienced provider by MediFind in the treatment of RASopathies. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Type 2 Diabetes (T2D), Hypercalcemia, Endoscopy, and Penectomy.

Hyojeong Han is a Transfusion Medicine specialist and a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 13 years. Dr. Han is rated as an Experienced provider by MediFind in the treatment of RASopathies. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Anemia, and Hemolytic Anemia. Dr. Han is board certified in American Board Of Pathology, 2021, American Board Of Pediatrics, 2021, and American Board Of Pediatrics, 2016.

Robert Keating, MD, is currently a McCullough distinguished professor, interim senior vice president, Neuroscience and Behavioral Medicine Center and chief of Neurosurgery at Children’s National Hospital. A graduate of Georgetown University Medical School, he completed a neurosurgery residency and fellowship in pediatric neurosurgery/craniofacial surgery at the Albert Einstein and Montefiore Medical Center in the Bronx, NY. Following his training, Dr. Keating served in the U.S. Navy and was stationed at the Oakland Naval Hospital serving as the chief from 1991-1994. After his time in the Navy, he returned to the Bronx where he was on staff at Montefiore Medical Center as well as the Bronx Municipal Hospital Center for two years before coming back to Washington, D.C., in 1996 to join the faculty at Children’s National Dr. Keating's past appointments include the president of the medical staff at Children’s National, as well as head of credentials. He currently maintains a busy practice of pediatric neurosurgery, with an emphasis on tumors, Chiari malformations, craniofacial reconstruction, spinal dysraphism, spasticity and brachial plexus surgery. As a member of the American Society of Pediatric Neurosurgery and International Society of Pediatric Neurosurgery, he has published and presented extensively in the field. His publications include the previous texts, “An Atlas of Orbitocranial Surgery” and “Tumors of the Pediatric Nervous System” (2nd edition published in 2013), with current work on Neurosurgical Operative Atlas, (2nd ed. Goodrich JT, and Keating RF, Thieme) due for publication in 2018. He is also chair, medical advisory committee on the Board of the American Syringomyelia Alliance Project as well as a founding member of the Posterior Fossa Society and maintains long-standing membership in the CNS, AANS, ASPN and ISPN. Dr. Keating is rated as an Experienced provider by MediFind in the treatment of RASopathies. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Craniosynostosis, Metopic Ridge, Chiari Malformation Type 1, Posterior Fossa Decompression, and Craniectomy. Dr. Keating is board certified in Neurological Surgery: American Board Of Neurological Surgery, 2000 and Neurological Surgery: American Board Of Neurological Surgery, 1993.

Mi Ran Shin, MD, MPH, is an assistant professor of pediatrics and a pediatric physiatrist at Children's National Hospital. She is a graduate of Cornell University and Korea University of Medicine. She completed her Physical Medicine and Rehabilitation training at Johns Hopkins Hospital and completed her Pediatric Rehabilitation Fellowship at Children’s National Hospital. She also completed her Master’s in Public Health at Johns Hopkins Bloomberg School of Public Health, with a focus on injury prevention for children with disabilities and advocacy for children with disabilities. Dr. Shin serves as pediatric physiatrist in a few multidisciplinary clinics including: Leukodystrophy Clinic, Neuro-oncology Clinic, Neurofibromatosis Clinic and Spina Bifida Clinic. She also serves a consultant in Safe Kids DC for children with disabilities and has a special interest in injury prevention. She is the associate program director for the Pediatric Rehabilitation Medicine Fellowship at Children’s National. Dr. Shin is rated as an Experienced provider by MediFind in the treatment of RASopathies. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Myelomeningocele, X-Linked Infantile Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 2, and Spinal Muscular Atrophy with Arthrogryposis. Dr. Shin is board certified in Pediatric Rehabilitation Medicine: American Board Of Physical Medicine And Rehabilitation, 2021 and American Board Of Physical Medicine And Rehabilitation, 2019.

Susan Whiteway is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 20 years. Dr. Whiteway is rated as an Experienced provider by MediFind in the treatment of RASopathies. Her clinical expertise encompasses Chromosome 7p Deletion, Ewing Sarcoma, RASopathies, and Osteosarcoma. Dr. Whiteway is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2013 and Pediatrics: American Board Of Pediatrics, 2009.

Seth Berger, MD, PhD, returned to Children’s National Hospital as faculty in 2018. He completed the medical scientist training program at Mount Sinai School of Medicine in New York where he was awarded his MD and PhD degrees. His research at that time focused on computational analysis of signaling networks applied to prediction of adverse drug events and cardiac arrhythmia syndromes. He subsequently completed the combined pediatrics and medical genetics residency program through Children's National and the National Human Genome Research Institute at the National Institutes of Health (NIH). He spent an additional year completing the medical biochemical genetics fellowship program at NIH before returning to Children's National where he was jointly hired by the Rare Disease Institute and the Center for Genetic Medicine Research. He is interested in developing novel bioinformatics approaches applied to variant discovery for rare diseases. Dr. Berger is rated as an Experienced provider by MediFind in the treatment of RASopathies. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Fetal Edema, Hydrops Fetalis, Hemolytic Disease of the Newborn, and Alpha Thalassemia. Dr. Berger is board certified in Medical Biochemical Genetics: American Board Of Medical Genetics And Genomics, 2019, Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 2017, and Pediatrics: American Board Of Pediatrics, 2016.

Diana Moya Orjuela, MD, works at Children's National in the Division of Gastroenterology, Hepatology and Nutrition. Dr. Orjuela is rated as an Experienced provider by MediFind in the treatment of RASopathies. Her clinical expertise encompasses Crohn's Disease, Morning Sickness, Delayed Growth, and Eosinophilic Esophagitis. Dr. Orjuela is board certified in Pediatrics: American Board Of Pediatrics, 2017 and Pediatrics: American Board Of Pediatrics, 2011.

Miriam Bloom, MD, is a hospitalist with Children's National Hospital. Dr. Bloom has a special interest in pediatric hospitalist medicine, pediatric hospitalist consulting, medical coordination of care for children with complex medical problems, Palliative care, and medical education. She is nationally and internationally recognized as well as an Inducted Faculty Member for AOA, Medical Honor Society 2001. Dr. Bloom is rated as an Experienced provider by MediFind in the treatment of RASopathies. Her clinical expertise encompasses Early Infantile Epileptic Encephalopathy, Wildervanck Syndrome, Koolen De Vries Syndrome, and Microcephaly Deafness Syndrome. Dr. Bloom is board certified in American Board Of Pediatrics, 2019, American Board Of Pediatrics, 2012, and Pediatrics: American Board Of Pediatrics, 1992.

Melissa Fleming is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 17 years. Dr. Fleming is rated as an Experienced provider by MediFind in the treatment of RASopathies. Her clinical expertise encompasses Encephalitis, Dysferlinopathy, Oculopharyngeal Muscular Dystrophy, and Fukuyama Type Muscular Dystrophy. Dr. Fleming is board certified in Pediatric Rehabilitation Medicine: American Board Of Physical Medicine And Rehabilitation, 2015 and Physical Medicine And Rehabilitation: American Board Of Physical Medicine And Rehabilitation, 2014.

Priya Vaidyanathan, MD, is a board-certified pediatric endocrinologist who has been on the staff of the Children's National Hospital since December 2005 soon after completing her pediatric endocrinology fellowship. She provides clinical care to patients with diverse endocrine needs, and her research interest is in the field of thyroid disorders. Dr. Vaidyanathan is rated as an Experienced provider by MediFind in the treatment of RASopathies. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Short Stature (Growth Disorders), Type 1 Diabetes (T1D), Diabetes Insipidus (DI), and Neurohypophyseal Diabetes Insipidus. Dr. Vaidyanathan is board certified in Pediatric Endocrinology: American Board Of Pediatrics, 2007 and Pediatrics: American Board Of Pediatrics, 2002.

Quyen Chu is a Surgical Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of RASopathies. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Pancreatic Cancer, Colorectal Cancer, Mastectomy, and Pancreatectomy.

David Jacobsohn, MD, ScM, MBA, is the division chief of the Blood and Marrow Transplantation Program at Children’s National Hospital and full professor of Pediatrics at the George Washington University. He leads a program of upwards of 70 pediatric transplants per year. The program performs transplants in patients with malignant and non-malignant conditions, and has expertise with all stem cell sources including haplo-identical transplants. His expertise is in graft-versus-host disease (GvHD) clinical trials: reducing incidence of GvHD as well as novel therapies for GvHD. He has more than 10 years of experience in clinical research in pediatric GvHD. His work has included the study of novel drugs for chronic GvHD, classification criteria for chronic GvHD, and risk factor stratification in pediatric chronic GvHD. He is active in the BMT community at a national level. Examples of some current and prior roles include head of the GVHD committee for the Pediatric Blood and Marrow Transplant Consortium, member-at-large of the that Consortium, member of the Children’s Oncology Group Stem Cell Transplant Committee, member of the Clinical Trials Network State of the Science Pediatric Advisory Group. Dr. Jacobsohn has been instrumental in growing the capabilities of the Blood and Marrow Transplant Program. For example, for the last five years the program is one of the few pediatric programs performing alpha/beta T cell depletion for haploidentical transplants. This novel method for GVHD prevention has significantly improved the outcome of haploidentical BMT at Children’s National. Additionally, he has been involved with the deployment of gene therapy for hemoglobinopathies. He successfully led Children’s National to become the first program in the country to collect stem cells for a commercial sickle cell gene therapy treatment. Dr. Jacobsohn is rated as an Experienced provider by MediFind in the treatment of RASopathies. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Hemoglobinopathy, Anemia, Sickle Cell Disease, and Bone Marrow Transplant. Dr. Jacobsohn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1999.